Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structure-based design of bitopic ligands for the µ-opioid receptor
Abdelfattah Faouzi, Haoqing Wang, Saheem A. Zaidi, et al.
Nature (2022) Vol. 613, Iss. 7945, pp. 767-774
Closed Access | Times Cited: 83

Showing 1-25 of 83 citing articles:

G protein-coupled receptors (GPCRs): advances in structures, mechanisms and drug discovery
Mingyang Zhang, Ting Chen, Xun Lu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 104
Direct interrogation of context-dependent GPCR activity with a universal biosensor platform
Remi Janicot, Marcin Maziarz, Jong‐Chan Park, et al.
Cell (2024) Vol. 187, Iss. 6, pp. 1527-1546.e25
Open Access | Times Cited: 21
Functional dynamics of G protein-coupled receptors reveal new routes for drug discovery
Paolo Conflitti, Edward Lyman, Mark S.P. Sansom, et al.
Nature Reviews Drug Discovery (2025)
Closed Access | Times Cited: 3
A cryptic pocket in CB1 drives peripheral and functional selectivity
Vipin Ashok Rangari, Evan S. O’Brien, Alexander S. Powers, et al.
Nature (2025)
Closed Access | Times Cited: 3
Molecular basis of opioid receptor signaling
Tao Che, Bryan L. Roth
Cell (2023) Vol. 186, Iss. 24, pp. 5203-5219
Open Access | Times Cited: 38
Structure, function and drug discovery of GPCR signaling
Lin Cheng, Fan Xia, Ziyan Li, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 33
A µ-opioid receptor modulator that works cooperatively with naloxone
Evan S. O’Brien, Vipin Ashok Rangari, Amal El Daibani, et al.
Nature (2024) Vol. 631, Iss. 8021, pp. 686-693
Closed Access | Times Cited: 14
In Vitro Functional Profiling of Fentanyl and Nitazene Analogs at the μ-Opioid Receptor Reveals High Efficacy for Gi Protein Signaling
Meng-Hua M. Tsai, Li Chen, Michael H. Baumann, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 4, pp. 854-867
Closed Access | Times Cited: 9
Designer cannabinoids could be the key to pain relief without adverse effects.
Iain R. Greig, Ruth A. Ross
PubMed (2025)
Closed Access | Times Cited: 1
Biased allosteric activation of ketone body receptor HCAR2 suppresses inflammation
Chang Zhao, Heli Wang, Ying Liu, et al.
Molecular Cell (2023) Vol. 83, Iss. 17, pp. 3171-3187.e7
Open Access | Times Cited: 22
ASD2023: towards the integrating landscapes of allosteric knowledgebase
Jixiao He, Xinyi Liu, Chunhao Zhu, et al.
Nucleic Acids Research (2023) Vol. 52, Iss. D1, pp. D376-D383
Open Access | Times Cited: 19
IUPHAR themed review: Opioid efficacy, bias, and selectivity
Nokomis Ramos‐Gonzalez, Barnali Paul, Susruta Majumdar
Pharmacological Research (2023) Vol. 197, pp. 106961-106961
Open Access | Times Cited: 18
Molecular dynamics-based identification of binding pathways and two distinct high-affinity sites for succinate in succinate receptor 1/GPR91
Aslihan Shenol, Michael Lückmann, Mette Trauelsen, et al.
Molecular Cell (2024) Vol. 84, Iss. 5, pp. 955-966.e4
Open Access | Times Cited: 8
AlphaFold accelerated discovery of psychotropic agonists targeting the trace amine–associated receptor 1
Alejandro Díaz‐Holguín, Marcus Saarinen, Duc Duy Vo, et al.
Science Advances (2024) Vol. 10, Iss. 32
Open Access | Times Cited: 8
Structural basis of μ-opioid receptor targeting by a nanobody antagonist
Jun Yu, Amit Kumar, Xuefeng Zhang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Highly biased agonism for GPCR ligands via nanobody tethering
Shivani Sachdev, Brendan A. Creemer, Thomas J. Gardella, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Carfentanil is a β‐arrestin‐biased agonist at the μ opioid receptor
Nokomis Ramos‐Gonzalez, Sam Groom, Katy J. Sutcliffe, et al.
British Journal of Pharmacology (2023) Vol. 180, Iss. 18, pp. 2341-2360
Open Access | Times Cited: 15
Structure-based identification of a G protein–biased allosteric modulator of cannabinoid receptor CB1
Siyuan Shen, Chao Wu, Guifeng Lin, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 24
Open Access | Times Cited: 5
Endogenous opiates and behavior: 2023
Richard J. Bodnar
Peptides (2024) Vol. 179, pp. 171268-171268
Closed Access | Times Cited: 5
Molecular glues as potential GPCR therapeutics
Bryan L. Roth, B. Krumm
Biochemical Pharmacology (2024) Vol. 228, pp. 116402-116402
Closed Access | Times Cited: 5
Signaling Modulation Mediated by Ligand Water Interactions with the Sodium Site at μOR
Rohini S. Ople, Nokomis Ramos‐Gonzalez, Qiongyu Li, et al.
ACS Central Science (2024) Vol. 10, Iss. 8, pp. 1490-1503
Open Access | Times Cited: 5
Allosteric modulation of G protein-coupled receptors as a novel therapeutic strategy in neuropathic pain
Chunhao Zhu, Xiaobing Lan, Zhiqiang Wei, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 1, pp. 67-86
Open Access | Times Cited: 11
A bitopic agonist bound to the dopamine 3 receptor reveals a selectivity site
Sandra Arroyo‐Urea, Antonina L. Nazarova, Ángela Carrión-Antolí, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Advances in the structural understanding of opioid allostery
Nokomis Ramos‐Gonzalez, Balázs Varga, Susruta Majumdar
Trends in Pharmacological Sciences (2025)
Open Access
Intracellular Pocket Conformations Determine Signaling Efficacy through the μ Opioid Receptor
David A. Cooper, Joseph DePaolo-Boisvert, Stanley A. Nicholson, et al.
Journal of Chemical Information and Modeling (2025)
Closed Access
Page 1 - Next Page

Scroll to top